Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Skyrizi²

This product is the most expensive of its product family


To avoid
As a precautionary measure

Contraindicated
Skyrizi² :
Type Medicine Authorised
Originator B
Agent Interpharma
Distributor Interpharma
Laboratory AbbVie
Responsible Party Abbvie Deutschland GmbH & Co KG
Origin Germany
Manufacturer Abbvie Biotechnology Ltd
Origin U.S.A.
ATC L04AC18

Your comment will appear shortly after approval

Skyrizi² :

Revision Date : 19/03/2020


Effect Frequency
Asthenia Common
Fatigue Common
Folliculitis Uncommon
Headache Common
Injection site bruising Common
Injection site erythema Common
Injection site haematoma Common
Injection site haemorrhage Common
Injection site irritation Common
Injection site pain Common
Injection site pruritus Common
Injection site reaction Common
Injection site swelling Common
Pruritus Common
Tinea infection Common
Upper respiratory tract infection Very Common

Different Units By MoH Code

Skyrizi²  MoH 11112 :
Form Solution for injection
Packaging Pre-filled pen
Package Size 1x0.83ml
Strength 75mg
Storage Condition 2-8°C Protect from light. Do not freeze
Public Price 4534779 L.L.
Stratum E2
NSSF ✘
Quarantine ✘
Reg. Number 103421/1
Submission date 2021
Registration Year 03/04/2023


Price Comparison

● Country: Lebanon
● Form: Solution for injection
● Package Size: 1x0.83ml
● Public Price: 4534779 LBP ( 4,534,779.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 4534779 LBP ( 4,534,779.00 LBP )
● Pricing Date: 13/06/2024

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Plaque psoriasis : (Adults)
● Cost/Unit: 4534779 LBP ( 4,534,779.00 LBP )
● Cost/Day: 9069558 LBP ( 9,069,558.00 LBP )
● Cost/Month: 18139116 LBP ( 18,139,116.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info